How to determine whether the material of medical plastic packaging meets chemical stability requirements?
Release Date:
2026-01-20
To assess the chemical stability of medical plastic packaging materials, it is necessary to combine standard testing methods with validation in real-world application scenarios. The core objective is to confirm that, throughout the entire lifecycle—from sterilization and storage to use—the material does not degrade, release harmful substances, or react with the packaged medical products. The specific approaches are as follows: Conduct compliance testing in accordance with national and international standards. Relevant tests shall be carried out in compliance with standards such as ISO 10993 (Biological evaluation of medical devices) and GB/T 16886, including: Extractables/Leachables Testing: Simulate sterilization and storage conditions to determine the levels of small-molecule substances leaching from the material into a simulated medium (e.g., water, ethanol), ensuring that the concentrations of these leachables remain within safe limits to prevent contamination of the packaged drugs or devices. Chemical Compatibility Testing: Directly contact the packaging with the packaged product, store under specified temperature and humidity conditions until the shelf life expires, and observe whether any chemical reactions occur, such as discoloration, swelling, cracking of the material, or changes in the product’s composition. Validation of Stability Under Simulated Sterilization Processes Different sterilization methods can affect the chemical stability of the material; therefore, post-sterilization performance testing is required: Steam Sterilization at High Temperatures: Test whether the material exhibits oxidative degradation or a reduction in molecular weight after repeated sterilization at 121°C or 134°C. Ethylene Oxide Sterilization: Determine the residual ethylene oxide and its derivatives in the material after sterilization, ensuring that their concentrations comply with the nationally prescribed safety limits. Gamma-Ray Sterilization: Verify whether the material generates toxic degradation products or experiences embrittlement, discoloration, or other adverse effects following irradiation. Long-Term Accelerated Aging Tests Conduct accelerated aging tests—such as increasing temperature and humidity—to simulate the storage conditions of the packaging during its shelf life and evaluate the material’s long-term stability: Analyze changes in the material’s chemical structure after aging using instruments such as infrared spectroscopy (IR) and differential scanning calorimetry (DSC). Assess whether the barrier properties and mechanical strength of the aged packaging have deteriorated, to prevent loss of the sterile barrier due to material degradation. Verification of Suitability for Clinical Application Scenarios Adjust test conditions according to the usage environment of the packaged product; for example: For reagent packaging used in low-temperature storage, test whether the material becomes brittle or releases substances under cold conditions. For packaging of implantable devices, conduct additional long-term in vivo simulation tests to confirm that any leachables from the material pose no risk of sensitization or mutagenicity.
To assess the chemical stability of medical plastic packaging materials, it is necessary to combine standard testing methods with validation in real-world application scenarios. The core objective is to confirm that, throughout the entire lifecycle—sterilization, storage, and use—the material does not undergo degradation, release harmful substances, or react with the packaged medical products. The specific methods are as follows:
Conduct compliance testing in accordance with national and international standards.
Targeted testing shall be conducted in accordance with standards such as ISO 10993 (Biological evaluation of medical devices) and GB/T 16886.
Extract/Leachate Testing: Simulate sterilization and storage conditions to determine the levels of small-molecule substances leaching from the material into a simulated solvent (such as water or ethanol), ensuring that the leachate concentrations remain within safe limits and preventing contamination of the packaged pharmaceuticals or medical devices.
Chemical compatibility testing: The packaging is brought into direct contact with the packaged product and stored under specified temperature and humidity conditions until the expiration date, during which any chemical reactions between the two—such as discoloration, swelling, cracking of the packaging material, or changes in the product’s composition—are observed.
Stability Verification of the Simulated Sterilization Process
Different sterilization methods can affect the chemical stability of materials, necessitating post-sterilization performance testing:
High-temperature steam sterilization: After repeated sterilization at 121°C and 134°C, the test material is examined for signs of oxidative degradation and molecular weight reduction.
Ethylene oxide sterilization: The residual levels of ethylene oxide and its derivatives in the material after sterilization must be tested and comply with the safety limits stipulated by national regulations.
Gamma-ray sterilization: Verify whether the material, after irradiation, produces toxic degradation products or exhibits embrittlement, discoloration, or other adverse effects.
Long-term accelerated aging test
Accelerated aging tests, such as increasing temperature and humidity, are conducted to simulate the storage conditions of the packaging throughout its shelf life and to evaluate the long-term stability of the materials:
The changes in the chemical structure of materials after aging can be analyzed using instruments such as infrared spectroscopy (IR) and differential scanning calorimetry (DSC).
Verify that the barrier properties and mechanical strength of aged packaging have not deteriorated, to prevent loss of the sterile barrier due to material degradation.
Validation of Applicability in Clinical Application Scenarios
Adjust the test conditions based on the operating environment of the interior components, for example:
Reagent packaging intended for low-temperature storage must be tested under cryogenic conditions to verify that the materials do not become brittle or crack and that no substances leach out.
Packaging for implantable devices shall undergo additional long-term in vivo simulation studies to confirm that material leachables pose no sensitization or mutagenic risk.
Recent News